IP Library › Patent Application 11180996
Patent Application
App. No. 11/180,996

Methods of treating acute pain using diclofenac

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/180,996
Abstract

New pharmaceutical compositions for oral use containing diclofenac preferably together with alkali metal bicarbonates in amounts of from about 20 to about 80 by weight with respect to diclofenac are described. These compositions are entirely palatable and free from any unpleasant taste or other, side effects; in particular, these formulations permit to obtain in human patients higher C max of the active principle and shorter T max together with a lower coefficient of variation.

Claims (38)

1 ) A method of treating acute pain comprising administering an immediate release oral dosage form comprising diclofenac potassium together with one or more alkali metal bicarbonates and customary excipients and adjuvants, wherein said alkali metal bicarbonates are present in an amount of greater than about 20% by weight based on the weight of diclofenac.

2 ) The method of claim 1 wherein said one or more alkali metal carbonates or bicarbonates are present in an amount of from about 20 to about 80% by weight based on the weight of diclofenac.

3 ) The method of claim 1 wherein said dosage form is a tablet comprising about 50 mg. of diclofenac potassium.

4 ) The method of claim 1 wherein said dosage form is a capsule comprising about 50 mg. of diclofenac potassium.

5 ) The method of claim 1 wherein said dosage form is a powder dosage form comprising about 50 mg. of diclofenac potassium dissolved or dispersed in water.

6 ) The method of claim 1 wherein said dosage form is a tablet comprising 25 mg. of diclofenac potassium.

7 ) The method of claim 1 wherein said dosage form is a capsule comprising 25 mg. of diclofenac potassium.

8 ) The method of claim 1 wherein said dosage form is a powder dosage form comprising 25 mg. of diclofenac potassium dissolved or dispersed in water.

9 ) The method of claim 1 wherein said dosage form is a tablet comprising 12.5 mg. of diclofenac potassium.

10 ) The method of claim 1 wherein said dosage form is a capsule comprising 12.5 mg. of diclofenac potassium.

11 ) The method of claim 1 wherein said dosage form is a powder dosage form comprising 12.5 mg. of diclofenac potassium dissolved or dispersed in water.

12 ) A method of treating acute pain comprising orally administering an immediate release oral dosage form comprising diclofenac in acid and/or salt form together with one or more alkali metal carbonates or bicarbonates and customary excipients and adjuvants, wherein said one or more alkali metal carbonates or bicarbonates are present in an amount of greater than about 20% by weight based on the weight of diclofenac.

13 ) The method of claim 12 wherein said one or more alkali metal carbonates or bicarbonates are present in an amount of from about 20 to about 80% by weight based on the weight of diclofenac.

14 ) The method of claim 12 wherein said dosage form is a tablet.

15 ) The method of claim 12 wherein said dosage form is a capsule.

16 ) The method of claim 12 wherein said dosage form is a powder dosage form dissolved or dispersed in water.

17 ) A method of treating acute pain comprising administering an immediate release pharmaceutical dosage form for oral use comprising diclofenac in acid and/or salt form and means for decreasing, average T max and increasing average C max of said diclofenac.

18 ) The method of claim 17 wherein said dosage form is a tablet comprising about 50 mg. of diclofenac potassium.

19 ) The method of claim 17 wherein said dosage form is a capsule comprising about 50 mg. of diclofenac potassium.

20 ) The method of claim 17 wherein said dosage form is a powder dosage form comprising about 50 mg. of diclofenac potassium dissolved or dispersed in water.

21 ) The method of claim 17 wherein said dosage form is a tablet comprising 25 mg. of diclofenac potassium.

22 ) The method of claim 17 wherein said dosage form is a capsule comprising 25 mg. of diclofenac potassium.

23 ) The method of claim 17 wherein said dosage form is a powder dosage form comprising 25 mg. of diclofenac potassium dissolved or dispersed in water.

24 ) The method of claim 17 wherein said dosage form is a tablet comprising 12.5 mg. of diclofenac potassium.

25 ) The method of claim 17 wherein said dosage form is a capsule comprising 12.5 mg. of diclofenac potassium.

26 ) The method of claim 17 wherein said dosage form is a powder dosage form comprising 12.5 mg. of diclofenac potassium dissolved or dispersed in water.

27 ) The method of claim 17 wherein said dosage form is a tablet comprising about 50 mg. of diclofenac sodium.

28 ) The method of claim 17 wherein said dosage form is a capsule comprising about 50 mg. of diclofenac sodium.

29 ) The method of claim 17 wherein said dosage form is a powder dosage form comprising about 50 mg. of diclofenac sodium dissolved or dispersed in water.

30 ) The method of claim 17 wherein said dosage form is a tablet comprising 25 mg. of diclofenac sodium.

31 ) The method of claim 17 wherein said dosage form is a capsule comprising 25 mg. of diclofenac sodium.

32 ) The method of claim 17 wherein said dosage form is a powder dosage form comprising 25 mg. of diclofenac sodium dissolved or dispersed in water.

33 ) The method of claim 17 wherein said dosage form is a tablet comprising 12.5 mg. of diclofenac sodium.

34 ) The method of claim 17 wherein said dosage form is a capsule comprising 12.5 mg. of diclofenac sodium.

35 ) The method of claim 17 wherein said dosage form is a powder dosage form comprising 12.5 mg. of diclofenac sodium dissolved or dispersed in water.

36 ) The method of claim 17 wherein said dosage form is a tablet comprising about 50 mg. of diclofenac potassium, and said tablet exhibits an average C max of from about 1750 to about 2000 and an average T max of from about 12 to about 25 minutes.

37 ) The method of claim 17 wherein said dosage form is a powder sachet comprising about 50 mg. of diclofenac potassium, and said sachet exhibits an average C max of from about 1500 to about 2000 and an average T max of from about 8 to about 20 minutes.

38 ) The method of claim 17 wherein said dosage form is a powder sachet comprising about 50 mg. of diclofenac potassium, and said sachet exhibits an average C max of from about 1900 to about 2500 and an average T max of from about 8 to about 20 minutes.

Assignments (3)
CHANGE OF NAME Recorded Jan 22, 2009
From: PROETHIC PHARMACEUTICALS, INC.
To: KOWA PHARAMCEUTICALS AMERICA, INC.
Reel/Frame 022137/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2006
From: APR APPLIED PHARMA RESEARCH SA
To: PROETHIC PHARMACEUTICALS, INC.
Reel/Frame 018425/0023 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2005
From: REINER, GIORGIO; REINER, ALBERTO
To: APR APPLIED PHARMA RESEARCH SA
Reel/Frame 016816/0026 →